IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 251 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $449 | -85.8% | 98,663 | -78.1% | 0.00% | -84.6% |
| Q2 2023 | $3,167 | +95.4% | 449,900 | +77.3% | 0.03% | +8.3% |
| Q4 2022 | $1,621 | -99.8% | 253,733 | +260.5% | 0.02% | +166.7% |
| Q3 2022 | $674,000 | -38.8% | 70,379 | -29.5% | 0.01% | -35.7% |
| Q2 2022 | $1,102,000 | -52.2% | 99,779 | -27.9% | 0.01% | -51.7% |
| Q1 2022 | $2,304,000 | +681.0% | 138,355 | +793.8% | 0.03% | +866.7% |
| Q4 2021 | $295,000 | -59.8% | 15,479 | -48.0% | 0.00% | -70.0% |
| Q3 2021 | $734,000 | -46.4% | 29,754 | -43.5% | 0.01% | -33.3% |
| Q2 2021 | $1,370,000 | -35.3% | 52,652 | +15.3% | 0.02% | -28.6% |
| Q4 2020 | $2,119,000 | +323.8% | 45,671 | +200.9% | 0.02% | +110.0% |
| Q3 2020 | $500,000 | -79.0% | 15,176 | -82.5% | 0.01% | -83.9% |
| Q2 2020 | $2,386,000 | – | 86,920 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,019,201 | $26,720,000 | 20.38% |
| Broadfin Capital, LLC | 5,951,153 | $52,668,000 | 6.92% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $49,271,000 | 6.23% |
| Avoro Capital Advisors LLC | 10,261,039 | $90,810,000 | 5.43% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $19,367,000 | 5.00% |
| Prosight Management, LP | 1,062,500 | $9,403,000 | 4.85% |
| Perceptive Advisors | 12,241,111 | $108,333,000 | 4.12% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,850,000 | 3.21% |
| QVT Financial LP | 1,021,361 | $8,696,000 | 2.84% |
| Vivo Capital, LLC | 1,600,000 | $14,160,000 | 1.81% |